epilepsy enterprises limited
epilepsy enterprises limited Company Information
Company Number
02052317
Registered Address
epilepsy society chesham lane, chalfont st peter, buckinghamshire, SL9 0RJ
Industry
Retail sale via mail order houses or via Internet
Telephone
01494601400
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
epilepsy society 100%
epilepsy enterprises limited Estimated Valuation
Pomanda estimates the enterprise value of EPILEPSY ENTERPRISES LIMITED at £6.6k based on a Turnover of £18.5k and 0.36x industry multiple (adjusted for size and gross margin).
epilepsy enterprises limited Estimated Valuation
Pomanda estimates the enterprise value of EPILEPSY ENTERPRISES LIMITED at £73.9k based on an EBITDA of £13k and a 5.69x industry multiple (adjusted for size and gross margin).
epilepsy enterprises limited Estimated Valuation
Pomanda estimates the enterprise value of EPILEPSY ENTERPRISES LIMITED at £34.9k based on Net Assets of £17.6k and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Epilepsy Enterprises Limited Overview
Epilepsy Enterprises Limited is a live company located in buckinghamshire, SL9 0RJ with a Companies House number of 02052317. It operates in the retail sale via mail order houses or via internet sector, SIC Code 47910. Founded in September 1986, it's largest shareholder is epilepsy society with a 100% stake. Epilepsy Enterprises Limited is a mature, micro sized company, Pomanda has estimated its turnover at £18.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Epilepsy Enterprises Limited Health Check
Pomanda's financial health check has awarded Epilepsy Enterprises Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
0 Regular
5 Weak
Size
annual sales of £18.5k, make it smaller than the average company (£324.6k)
£18.5k - Epilepsy Enterprises Limited
£324.6k - Industry AVG
Growth
3 year (CAGR) sales growth of -41%, show it is growing at a slower rate (6.1%)
-41% - Epilepsy Enterprises Limited
6.1% - Industry AVG
Production
with a gross margin of 76.8%, this company has a lower cost of product (36.6%)
76.8% - Epilepsy Enterprises Limited
36.6% - Industry AVG
Profitability
an operating margin of 70.1% make it more profitable than the average company (2.2%)
70.1% - Epilepsy Enterprises Limited
2.2% - Industry AVG
Employees
with 1 employees, this is below the industry average (4)
- Epilepsy Enterprises Limited
4 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Epilepsy Enterprises Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £18.5k, this is less efficient (£157.3k)
- Epilepsy Enterprises Limited
£157.3k - Industry AVG
Debtor Days
it gets paid by customers after 9 days, this is earlier than average (23 days)
9 days - Epilepsy Enterprises Limited
23 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Epilepsy Enterprises Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 1675 days, this is more than average (85 days)
1675 days - Epilepsy Enterprises Limited
85 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 29 weeks, this is more cash available to meet short term requirements (19 weeks)
29 weeks - Epilepsy Enterprises Limited
19 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 37.2%, this is a lower level of debt than the average (75.1%)
37.2% - Epilepsy Enterprises Limited
75.1% - Industry AVG
EPILEPSY ENTERPRISES LIMITED financials
Epilepsy Enterprises Limited's latest turnover from March 2023 is £18.5 thousand and the company has net assets of £17.6 thousand. According to their latest financial statements, we estimate that Epilepsy Enterprises Limited has 1 employee and maintains cash reserves of £5.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 18,513 | 15,764 | 12,343 | 91,551 | 91,913 | 88,751 | 84,458 | 67,070 | 97,294 | 58,931 | 143,002 | 175,657 | 176,765 | 148,789 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Cost Of Sales | 4,288 | 5,578 | 3,543 | 47,097 | 44,658 | 39,043 | ||||||||
| Gross Profit | 14,225 | 10,186 | 8,800 | 44,454 | 47,255 | 49,708 | ||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | 54,579 | 24,828 | ||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 10,794 | 4,980 | 2,619 | 29,083 | 43,213 | 48,289 | 54,579 | 24,828 | 49,588 | 30,123 | 86,829 | 129,581 | 126,431 | 99,342 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 10,794 | 4,980 | 2,619 | 29,083 | 43,213 | 48,289 | 54,579 | 24,828 | 49,588 | 30,123 | 86,829 | 129,581 | 126,431 | 99,342 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 10,794 | 4,980 | 2,619 | 29,083 | 43,213 | 48,289 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Number Of Employees | ||||||||||||||
| EBITDA* | 54,579 | 24,828 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 4,245 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 575 | 1,139 | 1,703 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 4,245 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 575 | 1,139 | 1,703 |
| Stock & work in progress | 19,688 | 15,851 | 14,873 | 16,150 | 19,397 | 19,464 | 17,099 | 9,263 | 6,650 | 8,491 | 7,367 | 6,513 | 5,678 | 6,971 |
| Trade Debtors | 480 | 480 | 480 | 480 | 1,576 | 1,307 | 480 | 1,440 | 7,232 | 480 | 6,101 | 12,384 | 7,172 | 16,579 |
| Group Debtors | 0 | 0 | 0 | 0 | 12,040 | 6,763 | 36,461 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,059 | 2,409 | 442 | 1,190 | 800 | 0 | 0 | 4,224 | 0 | 0 | 903 | 0 | 0 | 0 |
| Cash | 5,839 | 10,324 | 15,708 | 21,851 | 22,451 | 36,113 | 17,974 | 26,442 | 5,913 | 8,564 | 2,391 | 7,528 | 65,234 | 89,775 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 28,066 | 29,064 | 31,503 | 39,671 | 56,264 | 63,647 | 72,014 | 41,369 | 19,795 | 17,535 | 16,762 | 26,425 | 78,084 | 113,325 |
| total assets | 28,066 | 29,064 | 31,503 | 43,916 | 56,264 | 63,647 | 72,014 | 41,369 | 19,795 | 17,535 | 16,762 | 27,000 | 79,223 | 115,028 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 1,444 | 1,024 | 2,951 | 6,267 | 7,605 | 7,088 | 6,738 | 4,432 | 8,662 | 12,744 | 10,256 | 7,586 |
| Group/Directors Accounts | 5,005 | 12,608 | 17,432 | 9,646 | 0 | 0 | 54,579 | 24,828 | 4,957 | 5,003 | 0 | 6,156 | 60,867 | 99,342 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 5,439 | 4,648 | 3,600 | 2,000 | 2,150 | 991 | 1,730 | 1,353 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 10,444 | 17,256 | 22,476 | 12,670 | 5,101 | 7,258 | 63,914 | 33,269 | 11,695 | 9,435 | 8,662 | 18,900 | 71,123 | 106,928 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 10,444 | 17,256 | 22,476 | 12,670 | 5,101 | 7,258 | 63,914 | 33,269 | 11,695 | 9,435 | 8,662 | 18,900 | 71,123 | 106,928 |
| net assets | 17,622 | 11,808 | 9,027 | 31,246 | 51,163 | 56,389 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 |
| total shareholders funds | 17,622 | 11,808 | 9,027 | 31,246 | 51,163 | 56,389 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 | 8,100 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 54,579 | 24,828 | ||||||||||||
| Depreciation | 0 | 0 | 420 | 420 | 0 | 0 | 0 | 0 | 0 | 0 | 575 | 564 | 564 | 564 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 3,837 | 978 | -1,277 | -3,247 | -67 | 2,365 | 7,836 | 2,613 | -1,841 | 1,124 | 854 | 835 | -1,293 | 6,971 |
| Debtors | -350 | 1,967 | -748 | -12,746 | 6,346 | -28,871 | 31,277 | -1,568 | 6,752 | -6,524 | -5,380 | 5,212 | -9,407 | 16,579 |
| Creditors | 0 | -1,444 | 420 | -1,927 | -3,316 | -1,338 | 517 | 350 | 2,306 | -4,230 | -4,082 | 2,488 | 2,670 | 7,586 |
| Accruals and Deferred Income | 791 | 1,048 | 1,600 | -150 | 1,159 | -739 | 377 | 1,353 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 16,360 | 25,486 | ||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -7,603 | -4,824 | 7,786 | 9,646 | 0 | -54,579 | 29,751 | 19,871 | -46 | 5,003 | -6,156 | -54,711 | -38,475 | 99,342 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | -12,583 | -7,023 | -17,052 | -39,354 | -48,439 | -54,579 | 29,751 | 19,871 | -46 | 5,003 | -6,156 | -54,711 | -38,475 | 107,442 |
| cash and cash equivalents | ||||||||||||||
| cash | -4,485 | -5,384 | -6,143 | -600 | -13,662 | 18,139 | -8,468 | 20,529 | -2,651 | 6,173 | -5,137 | -57,706 | -24,541 | 89,775 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -4,485 | -5,384 | -6,143 | -600 | -13,662 | 18,139 | -8,468 | 20,529 | -2,651 | 6,173 | -5,137 | -57,706 | -24,541 | 89,775 |
epilepsy enterprises limited Credit Report and Business Information
Epilepsy Enterprises Limited Competitor Analysis
Perform a competitor analysis for epilepsy enterprises limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
epilepsy enterprises limited Ownership
EPILEPSY ENTERPRISES LIMITED group structure
Epilepsy Enterprises Limited has no subsidiary companies.
epilepsy enterprises limited directors
Epilepsy Enterprises Limited currently has 3 directors. The longest serving directors include Miss Catherine Alcock (Jul 2018) and Mr Andrew Gray (Dec 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Miss Catherine Alcock | United Kingdom | 67 years | Jul 2018 | - | Director |
| Mr Andrew Gray | United Kingdom | 61 years | Dec 2022 | - | Director |
| Mr Andrew James | 60 years | Dec 2022 | - | Director |
P&L
March 2023turnover
18.5k
+17%
operating profit
13k
0%
gross margin
76.9%
+18.92%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
17.6k
+0.49%
total assets
28.1k
-0.03%
cash
5.8k
-0.43%
net assets
Total assets minus all liabilities
Similar Companies
epilepsy enterprises limited company details
company number
02052317
Type
Private limited with Share Capital
industry
47910 - Retail sale via mail order houses or via Internet
incorporation date
September 1986
age
38
accounts
Small Company
ultimate parent company
previous names
nse enterprises limited (February 2011)
incorporated
UK
address
epilepsy society chesham lane, chalfont st peter, buckinghamshire, SL9 0RJ
last accounts submitted
March 2023
epilepsy enterprises limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to epilepsy enterprises limited.
epilepsy enterprises limited Companies House Filings - See Documents
| date | description | view/download |
|---|
